SEC Form 4 · accession 0001193125-26-335269
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary P Fischetti
Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2026 | P | 1,000 | $20.745 | A | 53,015 | D | |
| Common Stock | Aug 4, 2026 | P | 1,000 | $20.315 | A | 54,015 | D |
Table II — derivative securities
No Table II lines on this filing.